Does ROMOSOZUMAB-AQQG Cause Off label use? 419 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 419 reports of Off label use have been filed in association with ROMOSOZUMAB-AQQG. This represents 3.7% of all adverse event reports for ROMOSOZUMAB-AQQG.
419
Reports of Off label use with ROMOSOZUMAB-AQQG
3.7%
of all ROMOSOZUMAB-AQQG reports
9
Deaths
73
Hospitalizations
How Dangerous Is Off label use From ROMOSOZUMAB-AQQG?
Of the 419 reports, 9 (2.1%) resulted in death, 73 (17.4%) required hospitalization, and 6 (1.4%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROMOSOZUMAB-AQQG. However, 419 reports have been filed with the FAERS database.
What Other Side Effects Does ROMOSOZUMAB-AQQG Cause?
Fall (646)
Fracture (612)
Arthralgia (517)
Injection site pain (490)
Bone density abnormal (454)
Hospitalisation (381)
Headache (360)
Product storage error (348)
Death (263)
Spinal fracture (256)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ROMOSOZUMAB-AQQG Alternatives Have Lower Off label use Risk?
ROMOSOZUMAB-AQQG vs ROPEGINTERFERON ALFA-2B-NJFT
ROMOSOZUMAB-AQQG vs ROPINIROLE
ROMOSOZUMAB-AQQG vs ROPIVACAINE
ROMOSOZUMAB-AQQG vs ROSIGLITAZONE
ROMOSOZUMAB-AQQG vs ROSUVASTATIN